We at Roche Foundation Medicine are dedicated to transforming cancer care and continue to take steps to ensure that advanced cancer patients are receiving personalised care plans based on the results from comprehensive genomic profiling. With this in mind, we would like to introduce you to the #ProfileMe Program, a longitudinal support program designed to support advanced cancer patients.

We trust that this program will help alleviate the patient’s financial burden and more patients will benefit from personalised treatment via comprehensive genomic profiling. If you would like to understand the program pricing structure further, please contact us at +60 3 7628 5600 or malaysia.fmi@roche.com for Foundation Medicine Inc. (FMI) Comprehensive Genomic Profiling.